DECD:XETRA:XETRA-Amundi DAX 50 ESG UCITS ETF DR - EUR (C) (EUR)

ETF | Others |

Last Closing

USD 72.32

Change

+0.81 (+1.13)%

Market Cap

USD 0.02B

Volume

447.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.18 (+0.35%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.07 (+0.41%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.12 (+0.44%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.19 (+0.66%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.11 (+0.42%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.58%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+1.92 (+1.38%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.19 (+0.36%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.92 (+0.86%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+5.98 (+0.98%)

USD 80.38B

ETFs Containing DECD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.91% 76% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.91% 76% C+ 73% C
Trailing 12 Months  
Capital Gain 23.04% 72% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.04% 71% C- 71% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.38% 62% D 62% D
Dividend Return 9.38% 61% D- 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.44% 69% C- 75% C
Risk Adjusted Return 111.25% 95% A 96% N/A
Market Capitalization 0.02B 13% F 12% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.